Breitmeyer James B Insider Trades

Insider Trading History

Track insider trading activity for Breitmeyer James B. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vaxart
Vaxart VXRT
Director
Holding Value $47.3k 78,800 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.3k 78,800 shares
$0.74
$0.60
Vaxart
Vaxart VXRT
Director
Holding Value $94.5k 157,400 shares
Last Trade
Apr 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116k 157,400 shares
$0.74
$0.60
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $15k 28,400 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$318k 34,600 shares
$9.18
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $233k 443,034 shares
Last Trade
Jan 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$550k 55,440 shares
$9.92
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Oct 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$6.63M 1,190,390 shares
$5.57
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $395k 750,000 shares
Last Trade
Oct 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16M 2,601,140 shares
$6.16
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $260k 493,989 shares
Last Trade
Jul 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$370k 51,999 shares
$7.11
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $104k 196,544 shares
Last Trade
Apr 14, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$312k 50,000 shares
$6.25
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $77.2k 146,544 shares
Last Trade
Apr 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$569k 100,000 shares
$5.69
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $342k 650,000 shares
Last Trade
Feb 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.5M 757,196 shares
$19.20
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $285k 541,981 shares
Last Trade
Jan 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$594k 29,118 shares
$20.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $6.58k 12,500 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$260k 12,500 shares
$20.80
$0.53
Otonomy
Otonomy OTIC
Director
Holding Value $234 27,500 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.6k 27,500 shares
$1.95
$0.01
Zogenix
Zogenix ZGNX
Director
Holding Value $0 0 shares
Last Trade
Mar 07, 2022 Sale (Tender)Reported as Tender on SEC Form 4.
$32.5k 1,250 shares
$26.00
$26.68
Zogenix
Zogenix ZGNX
Director
Holding Value $0 0 shares
Last Trade
Mar 07, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.04M 76,625 shares
$26.68
$26.68
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $24.5k 46,544 shares
Last Trade
Jan 27, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$835k 25,000 shares
$33.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $335k 637,000 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.7M 637,000 shares
$38.80
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $86.9k 165,000 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.4M 165,000 shares
$38.80
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $202k 384,149 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.25M 128,557 shares
$48.60
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Executive Officer
Holding Value $3.58k 6,793 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$330k 6,793 shares
$48.60
$0.53

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up